정부/공공기관
임상시험센터
CRO
분석CRO/센트럴랩
유관기관/협회
정보서비스
해외 유관 기관
* CRO 게재 기준: CRO자율등록 기관
ClinicalTrials.gov에 등록된 정보를 기준으로 코로나-19(COVID-19) 관련 글로벌 임상시험 현황을 제공합니다.
전체 2550건이 검색되었습니다.
No. | Status | Study Title | Conditions | Interventions | Phase | Sponsor/Collaborators | Funder Type | Number Enrolled | Sex | Age | Locations |
---|---|---|---|---|---|---|---|---|---|---|---|
2067 | Active, not recruiting | Cell Therapy Using Umbilical Cord-derived Mesenchymal Stromal Cells in SARS-CoV-2-related ARDS | Severe Acute Respiratory Distress Syndrome | Biological: Umbilical cord Wharton's jelly-derived human Other: NaCl 0.9% |
Phase 2 | Assistance Publique - Hopitaux de Paris | OTHER | 47 | All | 18 Years | Hopital Pitie-Salpetriere - APHP, Paris, France Hopital Europeen Georges Pompidou - APHP, Paris, France |
2066 | Completed | Cellular Immuno-Therapy for COVID-19 Acute Respiratory Distress Syndrome | Covid19 | Biological: Mesenchymal Stromal Cells | Phase 2 | Ottawa Hospital Research Institute, Stem Cell Network, Ontario Research Fund | OTHER | 15 | All | 18 Years | The Ottawa Hospital, Ottawa, Ontario, Canada |
2065 | Recruiting | Cellular Immuno-Therapy for COVID-19 ARDS Randomized Clinical Trial | Acute Respiratory Distress Syndrome | Biological: UC-MSCs Biological: Placebo |
Phase 2 | Ottawa Hospital Research Institute, Canadian Institutes of Health Research (CIHR) | OTHER | 54 | All | 18 Years | Lakeridge Health, Oshawa, Ontario, Canada The Ottawa Hospital, Ottawa, Ontario, Canada St. Michael's Hospital, Toronto, Ontario, Canada Centre Hospitalier de l'Universite de Montreal, Montreal, Quebec, Canada |
2064 | Completed | Cerebrolycin for Treatment of Covid-related Anosmia and Ageusia | Covid19 Related Anosmia and Aguesia | Drug: Cerebrolysin | Phase 4 | Assiut University | OTHER | 100 | All | 20 Years ~ 60 Years | Assiut University Hospitals, Faculty of Medicine, Assiut, Egypt |
2063 | Withdrawn | Cetirizine and Famotidine for COVID-19 | Covid19 | Drug: Cetirizine and Famotidine Drug: Placebo |
Phase 4 | Emory University | OTHER | 0 | All | 18 Years | Emory University Hospital at Wesley Woods COVID-19 Testing Facility, Atlanta, Georgia, United States Emory Healthcare Network Peachtree Immediate Care COVID-19 Testing Centers, Atlanta, Georgia, United States |
2062 | Not yet recruiting | Changing Susceptible Body Constitution for COVID-19 Prevention by Chinese Medicine in Hong Kong Residents | Herbal Medicine | Drug: Yu-Ping-Feng formula Drug: Xiang-Sha-Liu-Jun formula Drug: Liu-Wei-Di-Huang formula Drug: Placebo for "Deficiency of Qi and Yang" Drug: Placebo for "Deficiency of Qi and Yin" |
Phase 2 | The University of Hong Kong | OTHER | 480 | All | 18 Years | The University of Hong Kong, Hong Kong, Hong Kong, China, Hong Kong |
2061 | Recruiting | Charite Trial of Cenicriviroc (CVC) Treatment for COVID-19 Patients | Covid19 | Drug: Cenicriviroc (CVC) Drug: Placebo |
Phase 2 | Charite University, Berlin, Germany, Allergan | OTHER | 183 | All | 18 Years | Medical Department of Hepatology and Gastroenterology, Charite University Medicine, Campus Virchow Klinikum (CVK) and Campus Charite Mitte (CCM), Berlin, Germany |